Literature DB >> 10628348

The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation.

M Pereira-Bittencourt1, D D Carvalho, A R Gagliardi, D C Collins.   

Abstract

Lectins have been used extensively as histochemical probes to describe changes in tumor cell surface and are known to influence the growth of cancer cells. In this study, we determined the effect of a lectin from the venom of Bothrops jararacussu (BJcuL) on the proliferation of a number of established human cancer cell lines. The growth of eight cancer cell lines was inhibited in a dose-related manner in the presence of BJcuL lectin. This lectin was most potent as an inhibitor of growth in renal (Caki-1 and A-498) and pancreatic (CFPAC-1) cancer cell lines with 50% inhibitory concentrations (IC50) of 1-2 mM. Melanoma (Wm115) and prostate (PC-3) cancer cells showed IC50 values of 7.9 and 8.5 mM, respectively, in the presence of BjcuL lectin whereas colon (Caco-2) and breast (MCF7) cancer cell lines showed no effect. Our results suggest that BJcuL lectin is an effective inhibitor of cell growth in some cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628348

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

Review 2.  Anticancer Activity of Toxins from Bee and Snake Venom-An Overview on Ovarian Cancer.

Authors:  Marius Alexandru Moga; Oana Gabriela Dimienescu; Cristian Andrei Arvătescu; Petru Ifteni; Liana Pleş
Journal:  Molecules       Date:  2018-03-19       Impact factor: 4.411

Review 3.  Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer.

Authors:  Gabrielle Wishart; Priyanka Gupta; Andrew Nisbet; Eirini Velliou; Giuseppe Schettino
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

Review 4.  Venom-based peptide therapy: insights into anti-cancer mechanism.

Authors:  Rui Ma; Ravikiran Mahadevappa; Hang Fai Kwok
Journal:  Oncotarget       Date:  2017-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.